pyroglutamyl-glutamyl-proline amide has been researched along with Carcinoid Tumor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Greef, WJ; de Herder, WW; Klootwijk, W; Krenning, EP; Kwekkeboom, DJ; Lamberts, SW; Visser, TJ | 1 |
| Autar, R; Boevé, ER; de Boer, R; de Greef, WJ; de Herder, WW; Jansen, CA; Klootwijk, W; Sleddens-Linkels, E; Visser, TJ | 1 |
2 other study(ies) available for pyroglutamyl-glutamyl-proline amide and Carcinoid Tumor
| Article | Year |
|---|---|
High serum levels of the thyrotropin-releasing hormone-like peptide pyroglutamyl-glutamyl-prolineamide in patients with carcinoid tumors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoid Tumor; Child; Chromatography, High Pressure Liquid; Female; Humans; Immune Sera; Male; Middle Aged; Pyrrolidonecarboxylic Acid; Radioimmunoassay; Reference Values; Thyrotropin-Releasing Hormone | 1996 |
Renal clearance of the thyrotropin-releasing hormone-like peptide pyroglutamyl-glutamyl-prolineamide in humans.
Topics: Adult; Aged; Anuria; Carcinoid Tumor; Chromatography, High Pressure Liquid; Constriction, Pathologic; Creatinine; Female; Humans; Kidney; Male; Middle Aged; Postoperative Period; Prostate-Specific Antigen; Prostatectomy; Pyrrolidonecarboxylic Acid; Reference Values; Thyrotropin-Releasing Hormone; Urologic Diseases | 1997 |